How do you translate an ISO 10993-5:2009 medical device cytotoxicity report without confusing in vitro cell viability with patient safety, an extract test with direct contact, or a laboratory observation with a regulatory approval? Manufacturers, biological evaluation specialists, quality teams and professional medical translators need bilingual records that preserve specimen identity, test design, controls, endpoints and qualified conclusions. A mistranslated percentage or unsupported ‘non-toxic’ claim can change how an overseas reviewer understands the biological evidence.
This guide explains how to translate ISO 10993-5 in vitro cytotoxicity reports, device extracts, cell-culture observations, viability measurements, test certificates and associated biological evaluation language. Its single search intent is practical: accurately transfer the meaning of one cytotoxicity test report across languages while keeping numerical results, experimental limitations and review responsibilities intact. It is not a general tutorial for all medical translation, an independent clinical safety review, or a substitute for the device manufacturer’s risk-management documentation.
The official ISO catalogue identifies ISO 10993-5:2009, Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity, as the published third edition, confirmed in 2022. Its stated scope concerns cultured mammalian cells exposed to a device or its extracts by direct contact or diffusion-based approaches. The test describes a laboratory biological response; it does not by itself determine every biological risk or establish clinical safety. This educational guide explains terminology and evidentiary boundaries without reproducing the copyrighted test method.
First establish the tested object
Before considering adjectives like acceptable, toxic or compliant, locate the laboratory’s actual test article. The device, the presented sample, any extracted liquid and the final commercial assembly can be related yet remain different objects. A translator’s first duty is to preserve their identity and the chain that links each statement to its specimen.
1. Device family and intended use
The label medical device may cover a broad product family while the report addresses only one submitted article. Keep intended purpose separate from the specimen tested. Treat this as an evidence boundary, not a vocabulary preference. The words determine which specimen or observation a reader is entitled to associate with the documented finding. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Calling a tested component the whole finished device can overstate the reach of the results. Marketing categories are not evidence of representative sampling. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A supplier tests a tubing compound, yet the translation declares every finished catheter biologically safe. Retain model, variant, material and intended-use statements exactly where the laboratory or manufacturer supplies them. Ask whether family-level claims have an approved technical rationale. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
2. Finished device versus material coupon
A molded sample, coating coupon, raw polymer and sterilized finished device can present different surface chemistry or residues. Report the actual state tested. In multilingual review, apparently minor substitutions accumulate. A good target sentence allows the independent specialist to recover the same experimental distinction without guessing. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Replacing ‘material specimen’ with ‘complete device’ suppresses the manufacturing boundary. Equally, a final product should not be reduced to an ingredient name. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
Two reports for the same polymer differ because only one specimen underwent the final production process. Compare the sample receipt page, item description and photo references. Keep each relevant processing or finishing condition linked to the tested object. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
3. Sample and batch identifiers
Lot numbers, laboratory accession identifiers and device serials are different keys, even when printed on the same page. Their exact characters are part of traceability. Technical trust depends on traceability: each translated phrase should point back to an identifiable field, table, observation or signed source conclusion. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A translated suffix that resembles a local-language word may be ‘corrected’ into another code, disconnecting the result from its physical specimen. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
Batch 08O is mistaken for 080 during transcription and an unrelated shipment is matched to the report. Keep identifiers verbatim, including capitalization, zeros and punctuation. Translate the field names, not the codes, and reconcile the report against the request form. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
4. Sterilization state
An unsterilized development sample and a terminally sterilized production configuration need not be biologically equivalent. State is an experimental property, not background decoration. Readers in procurement and regulatory affairs often see only the translated summary. That makes disciplined limits on claims particularly important at this point. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A phrase such as ‘sterile device’ in the target text can invent a process that the source never recorded, or hide that a tested article was untreated. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A distributor asks whether an extract came from the final sterilized configuration, but the source says only ‘as received’. Copy the described sterilization state and its reference without interpreting its adequacy. Escalate missing sterilization evidence to the responsible technical owner. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
5. Packaging contact history
Packaging materials, adhesives, processing aids and storage conditions can form part of a specimen’s history. The report may explicitly document them or omit them. An elegant synonym is not necessarily a defensible technical equivalent. Preserve the source’s level of specificity before improving its rhythm or readability. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A loose translation that equates packaged for shipment with sterile-barrier packaged creates unsupported assumptions about handling and contamination. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A test item arrives in a sealed pouch that the translator labels a validated sterile barrier without evidence. Preserve packaging descriptions and ‘not stated’ fields. Separate observable facts from a manufacturer’s later explanation of the sample history. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Understand the exposure pathway
A result belongs to a particular experimental arrangement. Direct contact, indirect contact and extract exposure are not stylistic variations of one sentence. The route by which the cell culture encountered the sample affects what the finding represents and whether one laboratory result can be compared sensibly with another.
6. Source document authority
The laboratory certificate, test protocol, submission form and biological evaluation report may describe overlapping facts under different responsibilities. The practical question is what an overseas reviewer could infer from this wording. If the new inference exceeds the source, the wording needs correction. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Combining several documents into one fluent paragraph can make a manufacturer’s interpretation appear to be a signed laboratory conclusion. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A client-facing summary turns a procurement request’s desired limit into a laboratory acceptance judgment. Attribute statements explicitly: the laboratory measured, the manufacturer supplied, and the biological evaluator concluded. Keep signatures and revision identifiers attached. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
7. Direct-contact exposure
Direct contact describes a cell-culture arrangement in which the test article contacts the cell system. That is not identical to device contact with human tissue. Numbers, labels and conditional statements travel together. Protecting one while changing another can make the bilingual report internally contradictory. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Translating ‘direct contact’ as direct patient exposure falsely moves a laboratory method into a clinical setting. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A microscopy note about cells beneath a specimen becomes a claim that a device touched live human tissue. Identify the cells, test material and stated exposure arrangement. Use the source method name consistently and avoid human-body analogies unless separately documented. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
8. Extract exposure
In an extract approach, a prepared liquid representing material-derived constituents is applied to a cell model. Its identity is not the device itself. Notice who performed the action described: laboratory analyst, manufacturer, evaluator or authority. Attribution is as important as subject-matter terminology. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Calling an extract ‘the product’ erases dilution, medium and preparation context. Calling it a ‘drug’ may also invent a pharmaceutical category. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
An overseas reviewer receives viability data for an extract but reads the translation as direct-contact results. Translate extract, extraction medium and test solution as distinct terms. Align preparation identifiers with the exact results table. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
9. Indirect contact and diffusion
Some arrangements separate the sample from the cell culture while allowing constituents to move through a medium. The physical separation matters to interpretation. Treat this as an evidence boundary, not a vocabulary preference. The words determine which specimen or observation a reader is entitled to associate with the documented finding. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
The word indirect should not be simplified to weak exposure, diluted exposure or absence of contact with any test-derived substance. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A summary claims no cells were exposed because the sample was not placed physically on the monolayer. Retain the stated barrier or diffusion arrangement as a laboratory description. Do not infer a stronger or safer response from its name. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
10. Extraction medium identity
A culture medium or other stated extraction vehicle forms part of test preparation and may affect what is recovered. Its identity needs precise naming. In multilingual review, apparently minor substitutions accumulate. A good target sentence allows the independent specialist to recover the same experimental distinction without guessing. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Generic ‘water extract’ can be wrong if the report specifies a different medium; vague ‘solution’ may hide a critical comparator. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
Two labs report different extract media, but a translation makes both appear to have used saline. Preserve the original medium designation, concentration and preparation reference. Query proprietary or abbreviated names rather than replacing them with guesses. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
11. Extraction conditions
Time, temperature, surface-area relation and other recorded preparation conditions define an extract’s experimental context. They should not be treated as optional prose. Technical trust depends on traceability: each translated phrase should point back to an identifiable field, table, observation or signed source conclusion. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A ’24-hour extraction’ must not become a ’24-hour cell incubation’. Swapping phases shifts the biological narrative. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A translator moves a numeric temperature from extract preparation into the later viability assay description. Check which event each time and temperature modifies. Reconcile the methods narrative against tables and sample-preparation worksheets. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Translate the biology without inventing clinical claims
Cytotoxicity testing uses cell-culture models to observe biological responses. The language of cell morphology, viability and controls can sound familiar while carrying narrowly defined scientific meanings. Keep observations, derived values and interpretive judgments in separate grammatical compartments.
12. Dilution and neat extract
Undiluted, neat and serially diluted extracts may be reported as separate conditions. The relative concentration cannot be assumed from adjectives alone. Readers in procurement and regulatory affairs often see only the translated summary. That makes disciplined limits on claims particularly important at this point. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A label like ‘100%’ is often a relative extract convention, not proof the material is chemically pure or risk-free. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A graph’s 50% extract is rewritten as ‘50% of the device’ and the recipient misunderstands exposure. Keep concentration labels tied to their original baseline and preparation scheme. Preserve order and test condition labels across tables and captions. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
13. Cell-line identity
The biological model is a specified cultured cell system, not a generic human patient or whole organism. Exact lineage names may determine comparability. An elegant synonym is not necessarily a defensible technical equivalent. Preserve the source’s level of specificity before improving its rhythm or readability. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Replacing a named line with ‘human cells’ can be both factually inaccurate and scientifically misleading. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A standardized mammalian cell line becomes an unsupported claim of testing on human tissue. Retain cell-line names and catalog identifiers in the source form. Translate surrounding explanations, not the formal biological designation. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
14. Cell-culture conditions
Culture conditions, handling and exposure duration provide context for interpreting growth and survival. A result has no free-standing meaning apart from its experiment. The practical question is what an overseas reviewer could infer from this wording. If the new inference exceeds the source, the wording needs correction. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A report of cells cultured under a defined condition must not be turned into general evidence of device stability in storage. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A buyer reads a culture incubation temperature as the temperature at which the medical device was stored. Keep the reported incubation period, temperature, gas environment and medium identities in the appropriate method clauses. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
15. Positive control
A positive control is chosen to demonstrate the assay’s capacity to detect an expected response, not to describe the sample’s approved quality. Numbers, labels and conditional statements travel together. Protecting one while changing another can make the bilingual report internally contradictory. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A translator may render positive as good, safe or passing, reversing the control’s role in a cytotoxicity assay. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
The certificate marks a positive control response and the marketing copy calls it proof of product biocompatibility. State control identity and purpose in scientifically neutral language. Verify that ‘positive response’ is not misrepresented as a favorable device outcome. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
16. Negative control
A negative control supports interpretation by showing an expected contrasting baseline under the stated method. It is not a second tested product. Notice who performed the action described: laboratory analyst, manufacturer, evaluator or authority. Attribution is as important as subject-matter terminology. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Translating negative as failed or rejected can make a properly functioning control appear to invalidate the study. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A procurement reviewer thinks the lab failed because its negative control is listed as ‘negative’. Keep the control label intact and explain its experimental role where readers may confuse ordinary and laboratory meanings. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Preserve numerical and statistical evidence
The bilingual report should be a dependable quantitative record. A percentage is meaningful only with its denominator, controls and endpoint. Uncertainty, replicate values, rounding, deviations and missing observations must not disappear because a simplified translation reads more smoothly.
17. Blank and vehicle controls
A blank or vehicle-only condition may track the measurement background or extraction medium. It has a different function from the product specimen. Treat this as an evidence boundary, not a vocabulary preference. The words determine which specimen or observation a reader is entitled to associate with the documented finding. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Collapsing blank, negative control and sample into one group can corrupt calculations and conceal baseline corrections. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
An optical readout is normalized to the wrong comparator after a table caption is shortened. Check the table legend and calculation notes before choosing equivalent target-language terms. Keep separate identifiers for each comparator. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
18. Cell morphology observations
Descriptions of rounding, detachment, lysis or other cell appearance belong to microscopy observations, not automatic conclusions about patients. In multilingual review, apparently minor substitutions accumulate. A good target sentence allows the independent specialist to recover the same experimental distinction without guessing. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Language that converts ‘some cells detached’ into ’tissue damage occurred’ extends beyond the observed in vitro system. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A sparse layer of rounded cells is translated into a diagnosis of injury in human tissue. Preserve qualitative qualifiers such as scattered, localized or widespread. Attach each observation to its sample and microscope time point. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
19. Viability and metabolic endpoints
Cell viability is an assay-dependent endpoint. A colorimetric or metabolic signal can be used to estimate relative cellular response under specific conditions. Technical trust depends on traceability: each translated phrase should point back to an identifiable field, table, observation or signed source conclusion. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Equating measured signal with the exact percentage of living cells in all circumstances can overstate what the assay measures. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A 72% relative signal becomes ‘72% of patients survived’ in a dangerously literal mistranslation. Report the assay name, calculation basis and reference control when available. Retain terms like relative viability or metabolic activity as written. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
20. Cytotoxicity versus other hazards
A cytotoxicity outcome concerns one biological response under one laboratory model; sensitization, irritation and systemic toxicity address different questions. Readers in procurement and regulatory affairs often see only the translated summary. That makes disciplined limits on claims particularly important at this point. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Changing ‘no cytotoxic effect observed’ into ‘non-allergenic and non-toxic’ invents several unsupported conclusions. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A device passes a cytotoxicity screen and the sales sheet claims comprehensive biological compatibility. Use a glossary that separates cytotoxicity, sensitization, irritation and toxicity endpoints; identify studies supporting each separately. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
21. Relative percentages and denominators
Percent viability, inhibition and response may use different denominators or reference controls. A number without its basis is not a transferable conclusion. An elegant synonym is not necessarily a defensible technical equivalent. Preserve the source’s level of specificity before improving its rhythm or readability. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
‘85% viability’ should not be silently converted to ‘15% toxicity’ unless the method and mathematical relationship justify it. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A supplier’s target-language chart labels viability reduction as viability, reversing the clinical review discussion. Trace each percentage to the report’s stated formula and comparator. Preserve inequality signs and decimal separators. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
22. Replicates and observation counts
Technical repeats, biological repeats, wells and independent test runs are not necessarily the same sample size. Report structure matters. The practical question is what an overseas reviewer could infer from this wording. If the new inference exceeds the source, the wording needs correction. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Calling three wells three patients, or treating replicate measurements as separate finished products, distorts evidentiary weight. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
Three repeated assay wells are presented as three independent devices and the stated confidence is overstated. Retain the laboratory’s exact replicate terminology and identifiers. Where a summary says n=3, check what n counts. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Keep judgments and responsibilities distinct
Laboratory findings, specification limits, device-level biological evaluation and regulatory decisions occupy different levels of authority. A reader needs to know which authority made a statement, using what documents and for which configuration of device. Translation must not manufacture a verdict that the source does not support.
23. Variation and error bars
Standard deviation, standard error, ranges and confidence intervals answer different questions about spread or estimation. Numbers, labels and conditional statements travel together. Protecting one while changing another can make the bilingual report internally contradictory. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A graph labelled SD must not be relabelled CI for apparent sophistication; the uncertainty communicated would change. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A plot’s error bars suddenly look like a regulatory confidence bound after a wrong caption translation. Compare figure legend, original numerical table and translated chart labels. Keep abbreviations consistent with the source. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
24. Detection and quantitation limits
A method can have limits for observing or quantifying a signal. A zero, a blank and a below-limit value are not synonymous. Notice who performed the action described: laboratory analyst, manufacturer, evaluator or authority. Attribution is as important as subject-matter terminology. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Translating ‘below detection’ as no substance or no response established can claim more than the system was able to observe. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A low assay signal is reported as absolute proof that a toxic constituent does not exist. Preserve less-than symbols and any specified detection or calculation limits. Explain the reporting convention only as far as the source supports. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
25. Method deviations
Laboratories may document departures from the planned procedure or justified changes. A translated report must preserve their timing and significance. Treat this as an evidence boundary, not a vocabulary preference. The words determine which specimen or observation a reader is entitled to associate with the documented finding. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Deleting a deviation because it seems embarrassing converts an imperfect but traceable study into a falsely clean record. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A different incubation duration is omitted from the bilingual copy and two studies are incorrectly compared. Keep deviations as explicit notes with their associated affected samples, steps and authorized technical assessments. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
26. Instrument and plate-reader data
Optical readings and instrument outputs may be intermediate measurements, not final normalized viability results. Units and processing stages matter. In multilingual review, apparently minor substitutions accumulate. A good target sentence allows the independent specialist to recover the same experimental distinction without guessing. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A raw absorbance number should not be presented as percentage viability or a direct clinical measurement. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
The translated spreadsheet replaces ‘absorbance’ with ‘cell survival’, obscuring normalization against controls. Retain the data column headings, wavelength references when supplied and calculation order. Ask the lab to explain ambiguous exports. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
27. Acceptance criteria
A report may apply a criterion from a protocol or an external specification, or may provide results without a formal pass/fail statement. Technical trust depends on traceability: each translated phrase should point back to an identifiable field, table, observation or signed source conclusion. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A translator who inserts ‘passed’ because one number seems high has taken responsibility for a technical judgment. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A manufacturer requests a pass/fail label that the signed laboratory report does not contain. Quote the source of any acceptance criterion accurately in paraphrase, including scope and responsible authority, without adding unlicensed criteria. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Release the translation as an auditable record
The final task is not merely linguistic elegance. A controlled bilingual dossier should allow a second reviewer to locate every crucial number, method description, sample ID, limitation and authorization in the original. When a contradiction remains, record it as an unresolved query rather than silently altering the scientific source.
28. Laboratory conclusions
Statements such as ‘no cytotoxic effect under the conditions tested’ are qualified by their model, endpoint and specimen. Readers in procurement and regulatory affairs often see only the translated summary. That makes disciplined limits on claims particularly important at this point. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Shortening that conclusion to ‘device is safe’ removes the condition and may mislead downstream regulatory or purchasing decisions. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A translated executive summary turns a limited cell-culture finding into approval for patient implantation. Preserve verbs of observation, evaluation and decision. Match the conclusion’s claim strength exactly and keep adverse findings visible. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
29. Biological evaluation linkage
ISO 10993-5 is one part of a larger device biological evaluation. Other evidence can concern chemistry, patient contact and specific risks. An elegant synonym is not necessarily a defensible technical equivalent. Preserve the source’s level of specificity before improving its rhythm or readability. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A single cytotoxicity report cannot be relabelled ‘full ISO 10993 certification’ without a separate documented basis. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
An auditor requests a biological evaluation report, but receives only a translated extract-test certificate. Link reports by ID rather than merging their conclusions. Refer broader risk conclusions to the manufacturer’s qualified evaluator. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
30. Historical study and revised edition
A historic test legitimately may cite an edition that is no longer the newest. Preserve the edition that governed the actual signed study. The practical question is what an overseas reviewer could infer from this wording. If the new inference exceeds the source, the wording needs correction. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Retrofitting a later edition date into a certificate is not a harmless update; it falsely represents what the laboratory followed. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A document archive replaces an older method identifier with ISO 10993-5:2009 without confirming the original study date. Keep standard numbers, years, corrigenda and protocol revisions verbatim. If modern requirements differ, discuss that separately. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
31. Regulatory and certification language
Regulators, notified bodies, accredited laboratories and product manufacturers play different roles. Their documents should not share invented approval verbs. Numbers, labels and conditional statements travel together. Protecting one while changing another can make the bilingual report internally contradictory. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
Accreditation of a laboratory is not necessarily approval of a device, and laboratory testing is not itself a market authorization. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A laboratory’s accreditation logo becomes a claim that a national health authority approved the device. Translate the exact credential, issuing body, tested scope and decision authority. Decline unsupported ‘certified safe’ language. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
32. Adverse and inconclusive results
A biological study can have unexpected, borderline or inconclusive observations. Retaining uncertainty is part of faithful scientific communication. Notice who performed the action described: laboratory analyst, manufacturer, evaluator or authority. Attribution is as important as subject-matter terminology. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A commercial editor may remove qualifiers like ‘possible interference’ or change ‘inconclusive’ to ‘acceptable’ to sound reassuring. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A colored extract disturbs a readout, but the target copy reports a definitive negative cytotoxicity conclusion. Keep unresolved observations, interferences and retest recommendations visible. Require authorized source correction rather than silent translation changes. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
33. Signed report revision
A final laboratory report, draft, amended report and translated rendering have distinct version histories and signatures. Treat this as an evidence boundary, not a vocabulary preference. The words determine which specimen or observation a reader is entitled to associate with the documented finding. Under ISO 10993-5 reporting, the goal is to describe the actual laboratory record rather than infer biological properties that were never measured.
A later translation may accidentally combine pages from two versions and appear more current than its source. The source may be technically correct while a convenient translation makes it broader, more certain or differently attributed. Compare the methods page with the result table and conclusions before accepting a smoother target-language formulation. Explain unfamiliar terminology briefly, but do not alter the underlying experimental claim.
A revised specimen identification arrives after translation, yet the old batch number remains in the final summary. Record original document number, issue date, amendment status, pages and translation revision. Make mismatched source pages a release blocker. A careful bilingual review asks whether the same reader, with no access to additional verbal assurances, would reach the same bounded interpretation in both languages. If not, preserve the original evidence, identify the ambiguity in a translator query and obtain a documented answer from the responsible source owner.
Worked example: why the source-to-target bridge matters
Imagine a manufacturer sends an overseas distributor a signed laboratory report stating that a particular device-material extract produced a reported level of relative cell viability under one assay. The distributor wants a simple sentence for a product listing. The translation should first state the test article, the method and the exact outcome; it should not turn a single assay into an unconditional promise that the finished device will cause no adverse effects. That stronger statement would require a separate, appropriately supported assessment.
Next imagine that the report lists a response at several extract concentrations. The correct bilingual summary retains each concentration and its associated result rather than selecting only the most favorable row or averaging data without authority. If a translation platform changes decimal punctuation, exponent notation or the direction of an inequality sign, verify the value against the signed table. The translator’s function is to transfer the data faithfully, not to design a new analysis.
Finally suppose the laboratory documented a deviation from a planned test condition and issued an amended certificate. A first translation based on an earlier draft cannot be released alongside the amendment as though both represent the same controlled version. Identify the source report’s revision and amend the translation under its own version control. This is how language becomes a trustworthy handoff rather than a parallel, unverified scientific record.
Practical release checklist for a medical-device cytotoxicity translation
Read the report once for scientific meaning and a second time for claim boundaries. Confirm model, lot, sample state, extraction method, cell line and controls; then audit each endpoint, concentration, measurement unit, calculation basis and reportable qualifier. Read tables independently from the narrative. Match every claimed result to the correct sample and control, and confirm that conclusions remain no stronger than those signed by the laboratory. Check the document edition, date, authorizations and any recorded deviations. A qualified medical-device biological evaluator, not the translator, owns the broader biological-risk conclusion.
For the official scope and current catalogue status see <a href=”https://www.iso.org/standard/36406.html”>ISO 10993-5:2009</a>. This focused technical article is a branch of <a href=”https://edukatesg.com/2026/09/18/master-art-of-translation-complete-system-moving-meaning-between-languages/”>Master Art of Translation</a>; the <a href=”https://edukatesg.com/vocabulary-learning-hub/”>Vocabulary Learning Hub</a> and <a href=”https://edukatesg.com/how-english-works-the-complete-map-and-learning-routes/”>How English Works</a> remain the canonical language-learning routes. These links provide context, not an alternative claim that this article is an authoritative medical-device test procedure.